Optiver Holding’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$220K Buy
+3,264
New +$217K ﹤0.01% 875
2026
Q1
Sell
-2,736
Closed -$182K 2430
2025
Q4
$182K Buy
+2,736
New +$177K ﹤0.01% 728
2025
Q3
Sell
-559
Closed -$48.8K 2742
2025
Q2
$48.8K Sell
559
-1,241
-69% -$97.3K ﹤0.01% 624
2025
Q1
$123K Buy
1,800
+1,379
+328% +$113K ﹤0.01% 438
2024
Q4
$32.7K Buy
+421
New +$31.2K ﹤0.01% 644
2024
Q3
Sell
-314
Closed -$35.6K 981
2024
Q2
$35.6K Buy
+314
New +$39.7K ﹤0.01% 590
2021
Q3
Sell
-292
Closed -$31K 741
2021
Q2
$31K Buy
+292
New +$28K ﹤0.01% 316

Other funds holding DXCM

Optiver Holding's DXCM Position: Q2 2026 in Review

Optiver Holding opened a new position in DexCom (DXCM) in Q2 2026: 3,264 shares worth $220K. The stake represents ﹤0.01% of the portfolio and ranks #875 among its holdings. This is a return to the name: Optiver Holding previously reported a position in DXCM as recently as Q4 2025.

Optiver Holding first reported a position in DXCM in Q2 2021 and has held it in 7 quarters since. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Optiver Holding held 3,264 shares of DexCom worth $220K as of Q2 2026.
  • DexCom was a new Optiver Holding position in Q2 2026.
  • DexCom made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #875 holding.
  • Optiver Holding first reported a position in DexCom in Q2 2021 and has held it in 7 quarters since.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.